| Clinical Study "Common" Name (formal title) | Number of enrollees | Funding source (pharma/NIH) | Year complete | Primary publication | Full study treatment protocol |
|---|---|---|---|---|---|
| RHONE-X Long-Term Extension [Four-year outcomes of faricimab in DME: Safety and efficacy results from the RHONE-X long-term extension trial] | n = 1474 |
NCT04432831 Hoffman-La Roche |
2024 | Khanani AM, Abreu F, Gibson K, et al. Four-year outcomes of faricimab in DME: First time safety and efficacy results from the RHONE-X long-term extension trial. Presented at the American Society of Retinal Specialists 2024 Annual Meeting; July 17, 2024; Stockholm, Sweden. |
|